Tamara Miljus

Tamara Miljus

Auto-generated profile, based on publicly available information

Tamara Miljus

Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2016 in Nature
Verified
Journal Article
Closed access
PDF file
AVAj Venkatakrishnan
Aj Venkatakrishnan
XDXavier Deupi
Xavier Deupi
GLGuillaume Lebon
Guillaume Lebon
FHFranziska M. Heydenreich
Franziska M. Heydenreich
TFTilman Flock
Tilman Flock
MBM. Madan Babu
M. Madan Babu

1 July 2021 in Physiological Reviews
Verified
Journal Article
Closed access
PDF file
DCDavide Calebiro
Davide Calebiro
ZKZsombor Koszegi
Zsombor Koszegi
YLYann Lanoiselée
Yann Lanoiselée
TMTamara Miljus
Tamara Miljus
SOShannon L O'Brien
Shannon L O'Brien
G protein-coupled receptors (GPCRs) regulate many cellular and physiological processes, responding to a diverse range of extracellular stimuli including hormones, neurotransmitters, odorants, and light. Decades of biochemical and pharmacological studies have provided fundamental insights into the mechanisms of GPCR signaling. Thanks to recent advances in structural biology, we now possess an atomistic understanding of receptor activation and G protein coupling. However, how GPCRs and G proteins interact in living cells to confer signaling efficiency and specificity remains insufficiently understood. The development of advanced optical methods, including single-molecule microscopy, has provided the means to study receptors and G proteins in living cells with unprecedented spatio-temporal resolution. The results of these studies reveal an unexpected level of complexity, whereby GPCRs undergo transient interactions among themselves as well as with G proteins and structural elements of the plasma membrane to form short-lived signaling nanodomains that likely confer both rapidity and specificity to GPCR signaling. These findings may provide new strategies to pharmaceutically modulate GPCR function, which might eventually pave the way to innovative drugs for common diseases such as diabetes or heart failure.

28 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FHFranziska M. Heydenreich
Franziska M. Heydenreich
TMTamara Miljuš
Tamara Miljuš
RJRolf Jaussi
Rolf Jaussi
RBRoger Benoit
Roger Benoit
DMDalibor Milić
Dalibor Milić
DVDmitry Veprintsev
Dmitry Veprintsev
Site-directed scanning mutagenesis is a powerful protein engineering technique which allows studies of protein functionality at single amino acid resolution and design of stabilized proteins for structural and biophysical work. However, creating libraries of hundreds of mutants remains a challenging, expensive and time-consuming process. The efficiency of the mutagenesis step is the key for fast and economical generation of such libraries. PCR artefacts such as misannealing and tandem primer repeats are often observed in mutagenesis cloning and reduce the efficiency of mutagenesis. Here we present a high-throughput mutagenesis pipeline based on established methods that significantly reduces PCR artefacts. We combined a two-fragment PCR approach, in which mutagenesis primers are used in two separate PCR reactions, with an in vitro assembly of resulting fragments. We show that this approach, despite being more laborious, is a very efficient pipeline for the creation of large libraries of mutants.

11 June 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
AMAdrian Morales-Pastor
Adrian Morales-Pastor
TMTamara Miljuš
Tamara Miljuš
MDMiguel Dieguez-Eceolaza
Miguel Dieguez-Eceolaza
TSTomasz Maciej Stępniewski
Tomasz Maciej Stępniewski
VLVicente Ledesma-Martin
Vicente Ledesma-Martin
JSJana Selent
Jana Selent
G protein-coupled receptors (GPCRs) are important therapeutic drug targets for a wide range of diseases. Upon activation, GPCRs can initiate several signaling pathways, each with unique therapeutic implications. Therefore, understanding how drugs selectively engage specific signaling pathways becomes paramount. However, achieving this selectivity remains highly challenging. To unravel the underlying multifaceted mechanisms, we integrate systematic mutagenesis of the CB2R, comprehensive profiling of Gαi2 and β-arrestin1 engagements and computer simulations to track the effects of mutations on receptor dynamics. Our research reveals multiple triggers within a complex allosteric communication network (ACN) that converge to preferential CB2R coupling by modulating evolutionarily conserved motifs. Utilizing network path analysis, we find that potent triggers are typically highly connected nodes and are located near regions of high information transmission within the ACN. Our insights highlight the complexity of GPCR signaling and provide a framework for the rational design of drug candidates tailored to evoke specific functional responses, ultimately enhancing the precision and efficacy of therapeutic interventions.

5 August 2025 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
SOShannon L. O’bRien
Shannon L. O’bRien
ETEmma Tripp
Emma Tripp
NBNatasja Barki
Natasja Barki
EBElodie Blondel-Tepaz
Elodie Blondel-Tepaz
GSGabrielle Smith
Gabrielle Smith
DCDavide Calebiro
Davide Calebiro
G-protein-coupled receptors (GPCRs) can signal from intracellular compartments but the occurrence and relevance of this phenomenon for metabolite-sensing GPCRs is largely unknown. Here, we investigate free fatty acid receptor 4 (FFA4), a metabolite-sensing GPCR activated by medium-chain and long-chain fatty acids. Using live-cell imaging, bioluminescence resonance energy transfer, super-resolution microscopy and cell fractionation, we show that FFA4 localizes to intracellular membranes, particularly endoplasmic reticulum subdomains surrounding lipid droplets, in both immortalized adipocytes and mouse adipose tissue. Upon lipolysis, locally released fatty acids appear to rapidly activate this intracellular FFA4 pool, leading to G i /o protein signaling and preferential reduction of cyclic adenosine monophosphate levels near lipid droplets. These mechanisms are required for efficient FFA4-mediated lipolysis regulation, as shown using tethered mini-Gα i/o proteins to locally inhibit G i/o signaling. These findings reveal an unexpected ‘intracrine’ GPCR signaling modality involved in the local regulation of cell metabolism, with biological and pharmacological implications.

10 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
TMTamara Miljuš
Tamara Miljuš
FHFranziska M. Heydenreich
Franziska M. Heydenreich
TGThais Gazzi
Thais Gazzi
AKAtsushi Kimbara
Atsushi Kimbara
MRMark Rogers-Evans
Mark Rogers-Evans
DVDmitry Veprintsev
Dmitry Veprintsev
Cannabinoid CB1 and CB2 receptors are members of the G protein-coupled receptor family, which is the largest class of membrane proteins in the human genome. As part of the endocannabinoid system, they have many regulatory functions in the human body. Their malfunction therefore triggers a diverse set of undesired conditions, such as pain, neuropathy, nephropathy, pruritus, osteoporosis, cachexia and Alzheimer’s disease. Although drugs targeting the system exist, the molecular and functional mechanisms involved are still poorly understood, preventing the development of better therapeutics with fewer undesired effects. One path toward the development of better and safer medicines targeting cannabinoid receptors relies on the ability of some compounds to activate a subset of pathways engaged by the receptor while sparing or even inhibiting the others, a phenomenon known as biased signaling. To take advantage of this phenomenon for drug development, a better profiling of the pathways engaged by the receptors is required. Using a BRET-based signaling detection platform, we systematically analyzed the primary signaling cascades activated by CB1 and CB2 receptors, including 9 G protein and 2 β-arrestin subtypes. Given that biased signaling is driven by ligand-specific distinct active conformations of the receptor, establishing a link between the signaling profiles elicited by different drugs and their chemotypes may help designing compounds that selectively activate beneficial pathways while avoiding those leading to undesired effects. We screened a selection of 35 structurally diverse ligands, including endocannabinoids, phytocannabinoids and synthetic compounds structurally similar or significantly different from natural cannabinoids. Our data show that biased signaling is a prominent feature of the cannabinoid receptor system and that, as predicted, ligands with different chemotypes have distinct signaling profiles. The study therefore allows for better understanding of cannabinoid receptors signaling and provides the information about tool compounds that can now be used to link signaling pathways to biological outcomes, aiding the design of improved therapeutics.